Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2019 09:00 ET | Source: Kannalife, Inc.

Kannalife Inc. Publishes New Research on Chemotherapy-Induced Peripheral Neuropathy

DOYLESTOWN, Pa., May 21, 2019 (GLOBE NEWSWIRE) -- Kannalife, Inc. (OTC:KLFE), Kannalife (“Kannalife” or “the Company”), a biopharmaceutical company leading innovation in research, development and...
August 01, 2018 08:00 ET | Source: Kannalife Sciences, Inc.

Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp.

NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is pleased to announce the completion of a share exchange...
May 18, 2018 09:00 ET | Source: Kannalife Sciences, Inc.

Kannalife Sciences to be Featured in Dateline NBC Segment Covering Company’s Research on CBD-Like Molecules as Treatments for HE, CTE

NEW YORK, May 18, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is excited to announce that the Company will be featured in a...
April 27, 2018 10:00 ET | Source: Kannalife Sciences, Inc.

Kannalife Sciences CEO Dean Petkanas to Provide Presentation on Industry Advancement at 2018 Cannabinoids in Medicine Summit

NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a phyto-medical company, announced today that the Company’s CEO Dean Petkanas will be presenting at the 2018...
February 29, 2016 09:00 ET | Source: Kannalife, Inc.

Kannalife Sciences Announces Feasibility Study With Catalent Pharma Solutions for the Development of a Novel Cannabinoid Therapeutic Agent to Treat CTE and HE

NEW YORK, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a Phyto-Medical Company, is pleased to announce the progress of its ongoing feasibility study being performed by...
February 18, 2016 09:00 ET | Source: Medical Marijuana Inc

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication Through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy

SAN DIEGO, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that the Company’s portfolio investment company, Kannalife Sciences, Inc. (“Kannalife”),...
February 16, 2016 11:15 ET | Source: Kannalife, Inc.

Kannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”

NEW YORK, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a Phyto-Medical Company, is pleased to announce the publication of the body of science behind KLS-13019, one of...
February 16, 2016 11:15 ET | Source: Kannalife, Inc.

Kannalife Sciences Announces Publication of “Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, With Improved Potency, Safety and Permeability”

NEW YORK, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a Phyto-Medical Company, is pleased to announce the publication of the body of science behind KLS-13019, one of...
December 22, 2015 13:57 ET | Source: Medical Marijuana Inc

Medical Marijuana, Inc. and Kannalife Sciences, Inc. Announce Joint Effort to Raise Awareness for CTE Research

NEW YORK, Dec. 22, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to shareholders and the public a joint effort with investment portfolio company Kannalife...
December 21, 2015 09:00 ET | Source: Kannalife, Inc.

Kannalife Sciences, Inc. and Gridiron Cannabis Coalition, LLC Sign Binding Memorandum of Understanding

NEW YORK, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc., a Phyto-Medical Company (“Kannalife”), announced the signing of a binding memorandum of understanding with Gridiron Cannabis...

Next Page keyboard_arrow_right